Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications

IP Trougakos, K Stamatelopoulos, E Terpos… - Journal of Biomedical …, 2021 - Springer
Background Gaining further insights into SARS-CoV-2 routes of infection and the underlying
pathobiology of COVID-19 will support the design of rational treatments targeting the life …

COVID19 biomarkers: What did we learn from systematic reviews?

S Semiz - Frontiers in cellular and infection microbiology, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …

Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines

N Aghamohamadi, F Shahba… - Frontiers in …, 2023 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is potentially pathogenic
and causes severe symptoms; in addition to respiratory syndromes, patients might …

[HTML][HTML] Management of COVID-19 patients with chronic liver diseases and liver transplants

X Hu, L Sun, Z Guo, C Wu, X Yu, J Li - Annals of hepatology, 2022 - Elsevier
The epidemic of coronavirus disease 2019 (COVID-19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has increasingly attracted worldwide …

[HTML][HTML] COVID-19-induced liver injury in infants, children, and adolescents

R Bitar, AA Elghoudi, D Rawat, A Azaz… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) typically presents with fever and respiratory
symptoms in children. Most children develop an asymptomatic and mild illness, with a …

COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms

M Du, S Yang, M Liu, J Liu - Clinics and Research in Hepatology and …, 2022 - Elsevier
Currently, there have been more than one hundred million confirmed cases of coronavirus
disease 2019 (COVID-19), with two million deaths worldwide. This has caused a huge …

Research landscape on COVID-19 and liver dysfunction: A bibliometric analysis

HZ Sa'ed - World Journal of Gastroenterology, 2023 - pmc.ncbi.nlm.nih.gov
BACKGROUND The global spread of severe acute respiratory syndrome coronavirus 2,
responsible for coronavirus disease 2019 (COVID-19), poses a significant risk to public …

Heterologous COVID-19 vaccination and booster with mRNA vaccine provide enhanced immune response in patients with cirrhosis: a prospective observational study

P Sripongpun, N Pinpathomrat, R Sophonmanee… - Vaccines, 2023 - mdpi.com
This study aimed to evaluate the antibody and cellular responses to different coronavirus
2019 (COVID-19) vaccination regimens in patients with cirrhosis and to assess the antibody …

Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management

SA Antar, NA Ashour, AO Hamouda, AM Noreddin… - …, 2024 - Springer
Since the start of the pandemic, considerable advancements have been made in our
understanding of the effects of SARS-CoV-2 infection and the associated COVID-19 on the …

[HTML][HTML] Smoking and Health Profiles of Hypertensive Patients with COVID-19: An Exploratory Study of Key Physiological Markers

L Haidar, MA Bălteanu, M Georgescu… - Journal of Clinical …, 2024 - mdpi.com
Background/Objectives: Smoking and hypertension are major contributors to cardiovascular
diseases, with smoker hypertensives typically presenting with exacerbated health risks …